MAP1LC3A and non-small cell lung carcinoma: Contrary to the reported adverse prognostic significance of SLS in the SqCC subgroup of NSCLC, using antibodies to the LC3 isoform LC3A [20], detection of SLS was rare and not associated with outcome in our cohort.